A decrease in the number of CD39+ Foxp3+ Tregs was observed in patients with multiple sclerosis (MS), indicating the importance of CD39 expression in Tregs in the management of inflammatory autoimmune diseases [69]. The gene discussed is ENTPD1; the disease is myeloid sarcoma.